Acute and regressive scleroderma concomitant to an acute CMV primary infection

J Clin Virol. 2014 Dec;61(4):604-7. doi: 10.1016/j.jcv.2014.10.003. Epub 2014 Oct 20.

Abstract

Objectives: To describe the pathophysiological mechanisms involving cytomegalovirus (CMV) primary infection and natural killer (NK) cell expansion in the development of localized scleroderma.

Results: A 43-year-old woman presented acute erythematous discoloration and skin thickening concerning face, neck, trunk, abdomen, and the four limbs, predominantly in proximal areas. Our case did not respond to systemic sclerosis criteria diagnosis. However, skin and muscle biopsy revealed early scleroderma associated with capillary thrombi, and tissue infiltration with NK cells (CD56+/Granzyme B). Scleroderma was attributed to CMV primary infection responsible for cytolytic hepatitis (7-fold over the limit) and circulating NK cell excess. After 6 months of prednisone and a 2-year follow-up, a complete resolution of symptoms was observed.

Conclusion: Our observation suggests a potential triggering role of CMV primary infection in the development of scleroderma. Histological features from our observation addresses the role of CMV and NK cells in the development of endothelial damage and fibrotic process.

Keywords: Connective tissue diseases; Cytomegalovirus; Natural killer cells; Scleroderma; Systemic sclerosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Biopsy
  • Cytomegalovirus Infections / complications*
  • Female
  • Histocytochemistry
  • Humans
  • Immunohistochemistry
  • Killer Cells, Natural / immunology
  • Microscopy
  • Muscles / pathology
  • Prednisone / therapeutic use
  • Scleroderma, Localized / diagnosis*
  • Scleroderma, Localized / immunology
  • Scleroderma, Localized / pathology*
  • Skin / pathology
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Prednisone